Leslie Eiland is an Endocrinology/Metabolic physician affiliated with Nebraska Medical Center. OpenAlex indexes 30 publications with 520 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Dept Of Diabetes Endocrinolgy & Metabolism
984120 Nebraska Medical Center
Omaha, NE 681984120
Telephone
402-559-6036Registry record last updated 8 Oct 2012.
Clinical trials
- Shared Medical Visits for Spanish-speaking Patients With Type 2 Diabetes
Sponsor: University of Nebraska
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20251 payment
- Novo Nordisk IncProgram year20252 payments
- Genentech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
58.4%Insulin Analog30.4%Novolog Flexpen17%Tresiba Flextouch U-20017%Humalog Kwikpen U-10013%Novolog13%Toujeo Solostar12%Humalog11%Lantus Solostar11%Tresiba Flextouch U-1007%Part D<11 patientsGLP-1 receptor agonist17.8%Ozempic56%Trulicity23%Mounjaro22%Part D<11 patients+ 2 more classes in this area
Hormonal (systemic)
25.4%l-Thyroxine15.8%Levothyroxine Sodium100%Part D≥17 patientsThyroid Hormone Synthesis Inhibitor9.5%Methimazole72%Propylthiouracil28%Part D<11 patientsSensory organs
10.3%Corticosteroid10.3%Hydrocortisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Andre Kalil, MD
Nebraska Medical Center
Mark Rupp, MD
Nebraska Medical Center
Christopher Kratochvil, MD
Nebraska Medical Center
Dwight Jones, MD
Nebraska Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”